Joshua D. Lee, MD, MSc
Associate Professor at the NYU Grossman School of Medicine; Co-Director of the Section on Tobacco, Alcohol, and Drug Use in the Department of Population Health and Director of the NYU Addiction Medicine Fellowship
Joshua D. Lee MD, MSc is an Associate Professor at the NYU Grossman School of Medicine. He is Co-Director of the Section on Tobacco, Alcohol, and Drug Use in the Department of Population Health and Director of the NYU Addiction Medicine Fellowship. He is an Internal Medicine and Addiction Medicine clinician researcher focused on low threshold addiction pharmacotherapy treatments in primary care and criminal justice settings. He has conducted multiple NIH clinical trials examining the use of naltrexone and buprenorphine opioid and alcohol treatments in community criminal justice involved adults, at release from jail, and within community primary care settings. He treats patients at Bellevue Hospital Center.
Dr. Lee is currently Contact MPI#1 of the NYU multisite RCT ‘Hub’ examining long-acting buprenorphine vs. naltrexone OUD treatments in CJS and post-release populations, funded through the NIDA Justice and Community Opioid Innovation Network (JCOIN). This study collaborates between NYU, Dartmouth, Yale, Friends Research Institute, and Oregon Health Science University. He leads a similar NIDA R01 MPI collaboration between NYC Correctional Health Services, NYC Dept. Health, and Cornell Univ. estimating associations between post-release overdose, recidivism, and health outcomes with in-jail methadone and buprenorphine treatment. Dr. Lee Co-Led the NIDA Clinical Trials Network 0051 multisite R01, ‘X:BOT,’ which established the comparative effectiveness of XR-Naltrexone OUD treatment compared to daily buprenorphine maintenance.
Dr. Lee lives in Manhattan, is married to a Psychiatrist, and has two young boys. He enjoys watching and playing soccer, long hikes, golf, and looking at his phone while at the gym. He was born in Knoxville, TN, and attended Princeton University and the University of Tennessee College of Medicine. He trained in Internal Medicine at NYU/Bellevue and received an MSc in Health Service Research and Clinical Epi at Cornell Weill Grad School of Medical Sciences.
twitter/@DrJoshuaDLee
Selected Publications
- Velasquez M, Flannery M, Badolato R, Vittitow A, McDonald RD, Tofighi B, Garment AR, Giftos J, Lee JD. Perceptions of extended-release naltrexone, methadone, and buprenorphine treatments following release from jail. Addict Sci Clin Pract. 2019 Oct 1;14(1):37. doi: 10.1186/s13722-019-0166-0. PMID: 31570100; PMCID: PMC6771097.
- Lee JD, Nunes EV Jr, Novo P, Bachrach K, Bailey GL, Bhatt S, Farkas S, Fishman M, Gauthier P, Hodgkins CC, King J, Lindblad R, Liu D, Matthews AG, May J, Peavy KM, Ross S, Salazar D, Schkolnik P, Shmueli-Blumberg D, Stablein D, Subramaniam G, Rotrosen J. Comparative effectiveness of extended-release naltrexone versus buprenorphine-naloxone for opioid relapse prevention (X:BOT): A multicentre, open-label, randomised controlled trial. Lancet. 2018 Jan 27;391(10118):309-318. doi: 10.1016/S0140-6736(17)32812-X. PMID: 29150198.
- Lee JD, Friedmann PD, Kinlock TW, Nunes EV, Boney TY, Hoskinson RA Jr, Wilson D, McDonald R, Rotrosen J, Gourevitch MN, Gordon M, Fishman M, Chen DT, Bonnie RJ, Cornish JW, Murphy SM, O'Brien CP. Extended-release naltrexone to prevent opioid relapse in criminal justice offenders. N Engl J Med. 2016 Mar 31;374(13):1232-42. doi: 10.1056/NEJMoa1505409. PMID: 27028913; PMCID: PMC5454800.
- Lee JD, McDonald R, Grossman E, McNeely J, Laska E, Rotrosen J, Gourevitch MN. Opioid treatment at release from jail using extended-release naltrexone: A pilot proof-of-concept randomized effectiveness trial. Addiction. 2015 Jun;110(6):1008-14. doi: 10.1111/add.12894. PMID: 25703440.
- Lee JD, Grossman E, DiRocco D, Gourevitch MN. Home buprenorphine/naloxone induction in primary care. J Gen Intern Med. 2009 Feb;24(2):226-32. doi: 10.1007/s11606-008-0866-8. PMID: 19089508; PMCID: PMC2628995.
- Magura S, Lee JD, Hershberger J, Joseph H, Marsch L, Shropshire C, Rosenblum A. Buprenorphine and methadone maintenance in jail and post-release: A randomized clinical trial. Drug Alcohol Depend. 2009 Jan 1;99(1-3):222-30. doi: 10.1016/j.drugalcdep.2008.08.006. Epub 2008 Oct 18. PMID: 18930603; PMCID: PMC2658719.